Cingulate therapeutics headquarters
WebCingulate Therapeutics has raised a total of $7.6M in funding over 3 rounds. Their latest funding was raised on Jul 11, 2024 from a Venture - Series Unknown round. Cingulate Therapeutics is registered under the ticker NASDAQ:CING . Their stock opened with $6.00 in its Dec 8, 2024 IPO. WebJul 11, 2024 · 11 Jul 2024 Cingulate CEO: $7.5M fundraising round will help drive pharma growth in KC. A former Marion Laboratories employee, Shane Schaffer’s goal from the …
Cingulate therapeutics headquarters
Did you know?
WebCingulate Therapeutics 9 years 11 months Chief Operating Officer Oct 2024 - Present5 years 7 months Kansas City, KS Founding member of … WebJul 11, 2024 · Jul 11, 2024. Updated Jul 11, 2024, 2:54pm CDT. Cingulate Therapeutics LLC, a Kansas City, Kan., pharmaceutical startup, received a big equity investment and …
WebMar 30, 2024 · EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML: 10 Mar 2024: 10-K: Annual report which provides a comprehensive overview of the company for the past year WebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on...
WebCingulate Therapeutics is a biopharmaceutical company developing products for the treatment of central nervous system and neurobiological disorders. WebView Arthur Straughn's business profile as Co-founder Board of Directors at Cingulate Therapeutics. Find Arthur's email address, mobile number, work history, and more. Product About Create Free Account. Wrong ... Arthur Straughn's HQ phone number is +1 913-942-2300. Who are Arthur Straughn's colleagues? Arthur Straughn's colleagues are Lou Horn ...
WebApr 3, 2024 · Cingulate Therapeutics doesn't have any recent trademark applications, indicating Cingulate Therapeutics is focusing on its existing business rather than …
WebJun 15, 2024 · The new Kansas City location is at 1901 Olathe Blvd. in Kansas City, KS. About Cingulate Therapeutics Cingulate Therapeutics, LLC is a privately held clinical stage biopharmaceutical... iram in the quranWebCingulate General Information. Description. Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery … orcs evWebCingulate is headquartered in Kansas City. For more information visit Cingulate.com. Forward-Looking Statements This press release contains certain forward-looking statements, including those relating to the use of proceeds and other statements that are predictive in nature. iram osman facebookWebWhere is Cingulate Therapeutics 's headquarters? Cingulate Therapeutics is located in Morristown, New Jersey, United States. Who … iram risicoanalyseWebCingulate currently has two (2) product candidates, CTX-1301 and CTX-1302, that are being developed to serve the approximate $18 billion annual U.S. ADHD market. A third product candidate, CTX-2103, is being developed to serve the roughly $5 billion U.S. … 10 Mar 2024 Cingulate Inc. Reports Fourth Quarter and Full Year 2024 Financial … Pipeline Overview. Cingulate® completed a proof-of-concept trial in human subjects … Cingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 … Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and … About Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage … Mr. Gallagher is a Co-Founder of Cingulate Therapeutics and serves as a member … iram locationWebCurt Medeiros' role at Cingulate Therapeutics is Independent Director, Board of Directors. What is Curt Medeiros' email address? ... What is Curt Medeiros' HQ phone number? Curt Medeiros' HQ phone number is +1 913-942-2300. What industry does Curt … iram iqbal twelveWebCingulate's headquarters are located at 1901 W 47th Pl, Kansas City, Kansas, 66205, United States What is Cingulate's phone number? Cingulate's phone number is (913) … iram sultan architect